MST1 and Insulin resistance: Inhibition of Mst1/2 phosphorylation by inhibitors IHMT‐MST1‐39 and ‐19 in diabetic mouse models demonstrated protection of β cells and associated depressions in levels of fasting glucose and improvements in insulin resistance (Wang, Qi, et al. 2023; Wu et al. 2022).